Juglans californica pollen

Identification

Summary

Juglans californica pollen is an extract from Juglans californica pollen used in allergy testing.

Generic Name
Juglans californica pollen
DrugBank Accession Number
DB10397
Background

Juglans californica pollen is the pollen of the Juglans californica plant. Juglans californica pollen is mainly used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • California black walnut pollen extract

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Calif. Black Walnut PollenInjection0.05 g/1mLCutaneous; Intradermal; SubcutaneousAllermed Laboratories, Inc.1974-03-12Not applicableUS flag
California Black WalnutInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
California Black WalnutInjection, solution40000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
California Black WalnutInjection, solution0.1 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
California Black WalnutInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Treatment Set TS333001Juglans californica pollen (0.002 g/1mL) + Amaranthus retroflexus pollen (0.002 g/1mL) + Ambrosia artemisiifolia pollen (4000 [AU]/1mL) + Canis lupus familiaris hair (0.002 g/1mL) + Carya tomentosa pollen (0.002 g/1mL) + Celtis occidentalis pollen (0.002 g/1mL) + Felis catus hair (400 [BAU]/1mL) + Phleum pratense pollen (4000 [BAU]/1mL) + Plantago lanceolata pollen (0.002 g/1mL) + Platanus occidentalis pollen (0.002 g/1mL) + Quercus alba pollen (0.002 g/1mL) + Rumex acetosella pollen (0.002 g/1mL) + Salsola kali pollen (0.002 g/1mL) + Urtica dioica pollen (0.002 g/1mL)Injection, solutionIntradermal; SubcutaneousAntigen Laboratories, Inc.1986-10-31Not applicableUS flag
Walnut MixJuglans californica pollen (0.0167 g/1mL) + Juglans nigra pollen (0.0167 g/1mL) + Juglans regia pollen (0.0167 g/1mL)InjectionPercutaneous; SubcutaneousAllermed Laboratories, Inc.1974-03-12Not applicableUS flag
Western Walnut Pollen MixJuglans californica pollen (0.025 g/1mL) + Juglans regia pollen (0.025 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Western Walnut Pollen MixJuglans californica pollen (20000 [PNU]/1mL) + Juglans regia pollen (20000 [PNU]/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
Western Walnut Pollen MixJuglans californica pollen (0.0005 g/1mL) + Juglans regia pollen (0.0005 g/1mL)SolutionIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
2147EPR64I
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910572
RxNav
852561

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
InjectionCutaneous; Intradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal; Subcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous40000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.001 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.05 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.1 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous40000 [PNU]/1mL
Injection, suspensionSubcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous
InjectionPercutaneous; Subcutaneous
SolutionIntradermal; Percutaneous; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53